Real-world Experience of Catheter Ablation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation

Description

The primary purpose of this registry is to obtain real-world clinical experience of Paroxysmal (PAF) and Persistent (PsAF) Atrial Fibrillation ablation radiofrequency (RF) technologies. Data from the registry will be used to assess clinical outcomes, including procedural efficiency, safety, and long-term, effectiveness of catheter ablation with novel RF technologies in PAF and PsAF patients.

Conditions

Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation

Talk to us

Study Overview

On this page

Study Details

Study overview

The primary purpose of this registry is to obtain real-world clinical experience of Paroxysmal (PAF) and Persistent (PsAF) Atrial Fibrillation ablation radiofrequency (RF) technologies. Data from the registry will be used to assess clinical outcomes, including procedural efficiency, safety, and long-term, effectiveness of catheter ablation with novel RF technologies in PAF and PsAF patients.

Real-world Experience of Catheter Ablation for the Treatment of Symptomatic ParoxysmaL and Persistent Atrial Fibrillation Using Novel CARTO Technologies: REAL AF Registry

Real-world Experience of Catheter Ablation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation

Condition
Paroxysmal Atrial Fibrillation
Intervention / Treatment

-

Contacts and Locations

Birmingham

University of Alabama at Birmingham, Birmingham, Alabama, United States, 35233

Birmingham

Grandview Medical Center, Birmingham, Alabama, United States, 35243

Mobile

Cardiology Associates of Mobile, Mobile, Alabama, United States, 36695

Chandler

Valley Heart Rhythm Specialists, Chandler, Arizona, United States, 85224

Jonesboro

Arrhythmia Research Group, Jonesboro, Arkansas, United States, 72401

Los Angeles

Keck School of Medicine, Los Angeles, California, United States, 90033

Santa Barbara

Santa Barbara Cottage Hospital, Santa Barbara, California, United States, 93105

Ventura

Community Memorial Hospital, Ventura, California, United States, 93303

Walnut Creek

University HealthCare Alliance, Walnut Creek, California, United States, 94598

Aurora

The Medical Center of Aurora, Aurora, Colorado, United States, 80012

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Symptomatic Paroxysmal (AF episode terminate spontaneously within 7 days) or Persistent (AF sustained beyond 7 days) who, in the opinion of the investigator, are candidates for ablation for AF
  • * 18 years of age or older
  • * De Novo ablation procedure unless it is a repeat for a patient whose index procedure is also in the registry
  • * Able and willing to participate in baseline and follow up evaluations for the full length of the registry
  • * Willing and able to provide informed consent, if applicable
  • * Enrolled in an investigational drug or device clinical trial, or any trial that dictates the treatment plan
  • * Long-standing persistent AF (AF greater than one year's duration)
  • * Having a repeat ablation, unless the subject's index ablation procedure is also included in the registry
  • * In the opinion of the investigator, any known contraindication to an ablation procedure

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Heart Rhythm Clinical and Research Solutions, LLC,

Study Record Dates

2027-12-31